Autolus Therapeutics (6A3A) Ownership - Who Owns Autolus Therapeutics?
Autolus Therapeutics (6A3A) Ownership Overview
- <0.01% Insiders
- 0.05% Mutual Funds
- 1.50% Other Institutional Investors
- 0.82% ETFs
- 97.62% Public Companies and Individual Investors
The ownership structure of Autolus Therapeutics (DE:6A3A) stock is a mix of institutional, retail, and individual investors. Approximately 2.38% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders, and 97.62% is owned by Public Companies and Individual Investors.
The ownership structure of Autolus Therapeutics (DE:6A3A) stock is a mix of institutional, retail, and individual investors. Approximately 2.38% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders, and 97.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 02, 2026 | Cintia Piccina | $15,641 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Stephen A. Schwarzman | 20,485,611 | Institution | 7.70% | 31,342,985 |
| Ishares | 1,697,138 | Institution | 0.64% | 2,596,621 |
| BlackRock, Inc. | 1,603,458 | Institution | 0.60% | 2,453,291 |
| Tema | 280,754 | Institution | 0.11% | 429,554 |
| John Hancock Investment Trust | 108,039 | Institution | 0.04% | 165,300 |
| State Street | 102,465 | Institution | 0.04% | 156,771 |
| Invesco | 65,177 | Institution | 0.02% | 99,721 |
| Activepassive | 31,733 | Institution | 0.01% | 48,551 |
| Trust For Professional Managers | 18,516 | Institution | <0.01% | 28,329 |
| Fidelity Concord Street Trust | 13,356 | Institution | <0.01% | 20,435 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| John Hancock Investment Trust | 108,039 | Institution | 0.04% | 165,300 |
| Trust For Professional Managers | 18,516 | Institution | <0.01% | 28,329 |
| Fidelity Concord Street Trust | 13,356 | Institution | <0.01% | 20,435 |
| Massmutual Select Funds | 2,605 | Institution | <0.01% | 3,986 |
| Locorr Investment Trust | 550 | Institution | <0.01% | 842 |
FAQ
Who Owns Autolus Therapeutics (DE:6A3A)?
According to the latest TipRanks data, approximately 2.38% of the company's stock is held by institutional investors, <0.01% is held by insiders, and 97.62% is held by public companies and individual investors.
What percentage of Autolus Therapeutics (DE:6A3A) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.38% of Autolus Therapeutics (DE:6A3A) stock is held by institutional investors: 0.05% by mutual funds, 0.82% by ETFs and 1.50% by other institutional investors.
What percentage of Autolus Therapeutics (DE:6A3A) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.62% of Autolus Therapeutics (DE:6A3A) stock is held by public companies and individual investors.
Who owns the most shares of Autolus Therapeutics (DE:6A3A)?
Stephen A. Schwarzman owns the most shares of Autolus Therapeutics (DE:6A3A).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
